Health
Vertical farming is being planted as the future of agriculture and the blossoming sector’s long-term growth could be a good fit for family investors and their patient capital.
The Covid-19 pandemic and its social and economic reverberations are triggering particularly salient challenges for family businesses. The first one relates to family business succession.
Devices to beat hospital-acquired infections, prevent opioid overdoses and instantly spot infections in blood are among the pioneering healthcare innovations being showcased to family investors at the upcoming MedTech Investing Europe Conference in Lausanne.
How is one Chinese biotechnology group succeeding in supporting the earliest stage of new drug discovery when global pharmaceutical companies have given up? Dr Jun Mao, founder and chairwoman of Viva Ventures, explains how it leverages its in-house expertise to invest in hundreds of biotech startups in the $20 trillion global pharmaceutical and biotechnology market.
Merck had been able to continually anticipate changes in the macro-environment and adapt itself
A trio of international family business academics reveal how a modest German pharmacy has evolved into a successful 12-generation dynasty complete with its own family university
Editor's Pick